CH
BLRX

CVI Holdings’s BioLineRX BLRX Stock Holding History

CVI Holdings’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$462K Buy
+20,392
New +$547K 0.4% 33

Other funds holding BLRX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CVI Holdings's BLRX Position: Q2 2024 in Review

CVI Holdings opened a new position in BioLineRX (BLRX) in Q2 2024: 20,392 shares worth $462K. The stake represents 0.4% of the portfolio and ranks #33 among its holdings.

31 funds tracked by Wall St. Rank hold BLRX as of Q2 2024.

  • CVI Holdings held 20,392 shares of BioLineRX worth $462K as of Q2 2024.
  • BioLineRX was a new CVI Holdings position in Q2 2024.
  • BioLineRX made up 0.4% of CVI Holdings's portfolio in Q2 2024, its #33 holding.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.